JuneBrain develops a telehealth eye-scanning system utilizing Optical Coherence Tomography (OCT) technology to enable remote monitoring of neurological and retinal diseases. This system addresses the challenge of limited access to timely assessments, facilitating earlier disease detection and improved treatment monitoring for patients outside traditional clinical settings.
Funding
$200K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Traditional clinical settings for neurological and retinal disease monitoring often present barriers to timely assessments, especially for patients in remote areas or those with mobility issues. This can lead to delays in diagnosis and treatment, potentially worsening patient outcomes.
Solution
JuneBrain offers a portable Optical Coherence Tomography (OCT) system and AI-powered software designed for remote monitoring of neurological and retinal diseases. The Neuro-i SS-OCT device is intended for use in point-of-care and clinical settings, providing accessibility for patients who may have difficulty reaching traditional facilities. The company's automated, quantitative analysis of OCT data supports neurological research and streamlines clinical trials. By expanding access to advanced care, JuneBrain aims to improve health outcomes for individuals with eye and brain diseases.
Target Audience
The primary target audience includes ophthalmologists, neurologists, and clinical researchers focused on neurological and retinal diseases, as well as healthcare providers seeking to expand access to advanced care in remote or point-of-care settings.
Features
- Portable Spectral-Domain OCT (SD-OCT) device for point-of-care retinal imaging
- AI-powered software for automated, quantitative analysis of OCT data
- Remote monitoring capabilities for neurological and retinal diseases
- Streamlined data analysis to enhance research and clinical trials